Julie Magat Selected Research

Julie Magat Research Topics

Disease

14	Neoplasms (Cancer) 04/2016 - 07/2010
3	Hypoxia (Hypoxemia) 01/2017 - 10/2012
2	Cicatrix (Scar) 01/2019 - 01/2019
1	Atherosclerotic Plaque (Atheroma) 03/2020
1	Myocardial Infarction 12/2018
1	Atrial Fibrillation 03/2017
1	Pulmonary Arterial Hypertension 01/2017
1	Necrosis 04/2016
1	Edema (Dropsy) 02/2016
1	Brain Neoplasms (Brain Tumor) 02/2016
1	Hypertrophy 01/2016
1	Heart Diseases (Heart Disease) 01/2016
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Tachycardia (Tachyarrhythmias) 01/2016
1	Breast Neoplasms (Breast Cancer) 03/2015
1	Brain Ischemia (Cerebral Ischemia) 01/2015
1	Stroke (Strokes) 01/2015
1	Kidney Neoplasms (Kidney Cancer) 03/2014
1	Fibrosarcoma 05/2013
1	Acute Promyelocytic Leukemia 01/2012
1	Leukemia 01/2012
1	Hyperthyroidism 06/2011

Drug/Important Bio-Agent (IBA)

6	Oxygen (Dioxygen)IBA 02/2016 - 06/2011
5	LipidsIBA 02/2016 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 04/2016 - 11/2014
3	Sorafenib (BAY 43-9006)FDA Link 04/2016 - 10/2012
3	carbogenIBA 11/2014 - 06/2011
2	Choline (Choline Chloride)IBA 04/2016 - 05/2013
2	fosbretabulin (combretastatin A4)IBA 02/2016 - 11/2014
2	LuciferasesIBA 03/2015 - 03/2014
1	MonocrotalineIBA 01/2017
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 04/2016
1	Small Interfering RNA (siRNA)IBA 04/2016
1	Phosphorylcholine (Phosphocholine)IBA 04/2016
1	Antineoplastic Agents (Antineoplastics)IBA 04/2016
1	gemcitabine triphosphateIBA 01/2016
1	Gemcitabine FDA Link 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	CalciumIBA 01/2016
1	Cytotoxins (Cytolysins)IBA 01/2016
1	Drug CombinationsIBA 01/2016
1	FluorineIBA 01/2016
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2016
1	rhodamine BIBA 03/2015
1	ferric oxide (iron oxide)IBA 03/2015
1	AcidsIBA 01/2015
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2015
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2015
1	Protons (Proton)IBA 11/2014
1	alovudineIBA 05/2013
1	Mitogen-Activated Protein KinasesIBA 10/2012
1	NitroimidazolesIBA 10/2012
1	mirdametinibIBA 10/2012
1	fluoroazomycin arabinosideIBA 10/2012
1	A-factor (Streptomyces)IBA 10/2012
1	Dihydrotachysterol (AT 10)IBA 10/2012
1	Aligeron (AS 2)IBA 01/2012
1	Arsenic Trioxide (Trisenox)FDA Link 01/2012
1	Thyroxine (Levothyroxine)FDA LinkGeneric 06/2011
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2010
1	S-nitrosocaptoprilIBA 07/2010

Therapy/Procedure

4	Therapeutics 04/2016 - 06/2011
3	Electrodes (Electrode) 01/2019 - 03/2017
3	Radiotherapy 05/2013 - 07/2010
2	Catheters 01/2019 - 03/2017
1	Stents 03/2020
1	Catheter Ablation 03/2017
1	Drug Therapy (Chemotherapy) 01/2016
1	Aftercare (After-Treatment) 05/2013